Page last updated: 2024-10-31

nocodazole and Sjogren's Syndrome

nocodazole has been researched along with Sjogren's Syndrome in 1 studies

Sjogren's Syndrome: Chronic inflammatory and autoimmune disease in which the salivary and lacrimal glands undergo progressive destruction by lymphocytes and plasma cells resulting in decreased production of saliva and tears. The primary form, often called sicca syndrome, involves both KERATOCONJUNCTIVITIS SICCA and XEROSTOMIA. The secondary form includes, in addition, the presence of a connective tissue disease, usually rheumatoid arthritis.

Research Excerpts

ExcerptRelevanceReference
"Upon brefeldin A treatment, p210 did not redistribute in the ER as did other Golgi proteins."1.29A peripheral protein associated with the cis-Golgi network redistributes in the intermediate compartment upon brefeldin A treatment. ( Antony, C; Boissier, MC; Bornens, M; Celati, C; Homberg, JC; Rios, RM; Tassin, AM, 1994)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Rios, RM1
Tassin, AM1
Celati, C1
Antony, C1
Boissier, MC1
Homberg, JC1
Bornens, M1

Other Studies

1 other study available for nocodazole and Sjogren's Syndrome

ArticleYear
A peripheral protein associated with the cis-Golgi network redistributes in the intermediate compartment upon brefeldin A treatment.
    The Journal of cell biology, 1994, Volume: 125, Issue:5

    Topics: Autoantigens; Brefeldin A; Calcimycin; Cell Compartmentation; Cell Line; Cyclopentanes; Electrophore

1994